What are the current strategies for preventing and treating viral infections in newborns?
Best insight from top research papers
Current strategies for preventing and treating viral infections in newborns include timely and specific identification of viral infections using molecular tools for viral detection . Antiviral therapeutic agents are available and can be lifesaving, so appropriate treatment is crucial . Prevention of congenital cytomegalovirus (CMV) infection is a promising direction for research, with studies showing a reduction in vertical transmission of CMV with the use of valaciclovir . Another approach involves the use of pine needles polyprenyl phosphate (PPP), which has shown versatile antiviral effects against various viruses in experimental models . In the case of the 2019 novel coronavirus disease (COVID-19), special preparations and protective equipment are necessary in delivery rooms or operating rooms serving infected mothers . For neonatal herpes simplex disease (HSV), early clinical suspicion and parenteral antiviral treatment are essential, followed by suppressive therapy with oral acyclovir .
Answers from top 4 papers
More filters
| Papers (4) | Insight |
|---|---|
Journal Article 1 Citations | The provided paper specifically focuses on the prevention and management of herpes simplex virus (HSV) infection in newborns. It does not discuss strategies for preventing and treating viral infections in general. |
| The provided paper does not mention the current strategies for preventing and treating viral infections in newborns. The paper focuses on proposing measurements for the prevention and control of COVID-19 in neonates. | |
4 Citations | The provided paper discusses prevention strategies for congenital cytomegalovirus (CMV) infection, but it does not specifically address strategies for preventing and treating viral infections in newborns. |
| The provided paper does not discuss strategies for preventing and treating viral infections in newborns. |
Related Questions
How the structural newborn care can prevent the nosocomial infection?5 answersStructural newborn care plays a crucial role in preventing nosocomial infections in neonatal intensive care units (NICUs). Key strategies include maintaining an adequate nurse-to-bed ratio, avoiding overcrowding and understaffing, providing easy access to handwashing facilities, organizing regular training sessions for caregivers, implementing continuous monitoring, and establishing surveillance systems for infection rates. Additionally, promoting breastfeeding, implementing strict hygiene measures, and ensuring meticulous attention to detail in invasive procedures like central catheter maintenance and ventilation support are essential in reducing infection rates. Furthermore, the use of bioactive substances like lactoferrin, probiotics with immunomodulatory properties, and antifungal drugs can also aid in infection prevention. Overall, a comprehensive approach encompassing structural organization, hygiene practices, and innovative prophylactic measures is vital in combating nosocomial infections in newborn care settings.
How can HEV infections be prevented?5 answersHEV infections can be prevented through various strategies. Firstly, the development of effective vaccines is crucial. Currently, the HEV 239 vaccine in China and the P206@PLGA veterinary vaccine candidate show promise in providing protection against HEV. Additionally, implementing measures to eliminate HEV from pork production, such as sensitive testing, early weaning, and antiviral treatments, can help reduce transmission to humans. Furthermore, improving hygienic standards and socioeconomic conditions can lower susceptibility to infection, as seen in countries transitioning from intermediate to low endemicity levels for HAV. Overall, a combination of vaccination, improved sanitation, and control measures in both animals and humans is essential in preventing HEV infections and reducing the global burden of the disease.
What are the treatments for congenital cytomegalovirus?5 answersTreatment options for congenital cytomegalovirus (CMV) infection include antiviral drugs such as ganciclovir and valganciclovir. Infants with life-threatening symptoms are recommended to receive intravenous ganciclovir for 2-6 weeks, followed by oral valganciclovir. However, the decision to treat paucisymptomatic cases is not straightforward, and additional diagnostic tests such as s2-microglobulin determination in cerebrospinal fluid and magnetic resonance imaging can aid in the decision-making process. Timely administration of antiviral therapy has been shown to be effective in managing symptomatic cases of congenital CMV. It is important to note that asymptomatic patients are also at risk of developing long-term clinical sequelae, so the role of antiviral therapy in silent cases needs further study. Overall, a well-timed delivery of pharmacological and non-pharmacological interventions is necessary to achieve healthy developmental outcomes for infants with congenital CMV infection.
What are the best methods for preventing and treating coronavirus?5 answersThe best methods for preventing and treating coronavirus include the use of CCR5 binding agents, isomyosmine or its pharmaceutically acceptable salt, FDA-approved and preclinical drugs targeting viral conserved elements, feeding the viruses nonprimordial isotopes of certain elements, and administering neurotransmitter inhibitors, signaling kinase inhibitors, estrogen receptor inhibitors, DNA metabolism inhibitors, or anti-parasitic agents. These methods have shown potential in inhibiting viral infections, reducing oxidative stress, inhibiting mitochondrial reactive oxygen species, inactivating viruses, inducing and controlling mutations, and treating coronavirus infections.
What is the best vaccine for rotavirus in newbornes?5 answersThe best vaccine for rotavirus in newborns is the oral human neonatal rotavirus vaccine (RV3-BB). This vaccine was evaluated in a randomized, double-blind, placebo-controlled trial in Indonesia and showed efficacy in preventing rotavirus gastroenteritis. Traditional vaccine schedules administer doses at 8 weeks, 14 weeks, and 18 weeks of age, which may not provide early protection for neonates. The RV3-BB vaccine, on the other hand, can be administered at birth, targeting early prevention of rotavirus gastroenteritis. Another study compared two globally licensed vaccines, RotaTeq and Rotarix, and found that measuring rotavirus IgA antibodies using the RotaTeq antigen resulted in higher estimations of immunogenicity. Therefore, the RV3-BB vaccine administered at birth may be the most effective option for preventing rotavirus in newborns.
How are viral diseases cured?9 answers